Complement system • The term complement refers to the ability of a system of some nonspecific proteins in normal human serum to complement, i.e., augment the effects of other components of immune system, such as antibody. • It is an important component of the human innate host defense system, consists of approximately 20 proteins that are present in normal human serum. Properties of the Complement System • It is present in sera of all mammals including humans and in lower animals including birds, amphibians, and fishes.
• These are heat-labile substances that are
inactivated by heating serum at 560C for 30 minutes. Cont. • These are glycoproteins and are synthesized primarily by liver cells and to a very less extent by macrophages and many other cell types • The complement usually does not bind to the antigen or antibody but only to antigen - antibody complex. • The importance of the complement lies in the fact that it contributes to both the acquired and innate immunity of an individual Complement Activation Pathways In the innate immune system , complement can be activated in two ways:
• Alternative pathway, in which antigen is
recognized by particular characteristics of its surface, or
• Mannan-binding lectin ( MBL) pathway
Cont. In the adaptive immune system complement is activated via;
• Classical pathway that begins with antigen-
antibody complexes Functions of the complement systems Functions of complement include;
• Lysis of bacteria, and fungal cells, viruses, etc.
• Promotion of phagocytosis (opsonization)
• Triggering of inflammation
• Secretion of immunoregulatory molecules
Cont. • Clearance of immune complexes from circulation
• Producing chemotactic substances
• Increasing vascular permeability
• Stimulate the smooth muscle contraction
promoting mast cell degranulation
Complement nomenclature
• Components C1 through C9, B, D, and P are
native complement (protein) components.
• Fragments of native complement components
are indicted by lowercase letter (e. g . , C4a, C5b, Bb). Smaller cleavage fragments are assigned the letter "a,'' and major (larger) fragments are assigned the letter "b." Cont.
• A horizontal bar above a component or
complex indicates enzymatic activity (e. g . , C4bC2b) . Alternative pathway • The alternative pathway is initiated by cell- surface constituents that are recognized as foreign to the host, such as LPS.
• Various enzymes (e.g . , kallikrein , plasmin ,
elastase) cleave C3, the most abundant serum complement component into C3a and C3b. Cont. • Unstable C3b fragment, is the major opsonin of the complement system and readily attaches to receptors on microbial cell surfaces. • C3b binds Factor B . • Factor B in the complex is cleaved by Factor D to produce C3bBb, an unstable C3 convertase Alternative pathway of complement activation. Beginning with the binding of C3b to a microbial surface, this pathway results in an amplified production of C3b and formation of a C5 convertase Alternative pathway of activation of the complement Cont. • Two proteins, C3b inactivator (I) and β1 H- globulin (H), function as important negative regulators, making an inactive form of C3b to prevent the unchecked over amplification of the alternative pathway.
• Alternatively, C3bBb binds properdin (Factor P)
to produce stabilized C3 convertase, C3bBbP. Cont. • Additional, C3b fragments join the complex to make C3bBbP3b, also known as C5 convertase. C5 convertase cleaves C5 into C5a and C5b.
• C5b inserts into the cell membrane and is the
necessary step leading to formation of the membrane attack complex (MAC) and cell lysis. Cont. • The membrane-bound C5b–6–7 complex acts as a receptor for C8 and C9. C8, on binding to the complex, stabilizes the attachment of the complex to the foreign cell membrane. • The C5b–8 complex acts as a catalyst for C9, which is a single chain glycoprotein with a tendency to polymerize spontaneously Cont. • The C5b-8 complex on binding to C9 molecules undergoes polymerization, which finally ends in the formation of C5b-9 complex also known as MAC. • The MAC forms a trans-membrane channel of 100 Å diameter in the cell. This trans-membrane channel allows the free exchange of ions between the cell and the surrounding medium. Cont. • This influx of water, swelling of the cell, and, for certain cell types, rupture of the cell membrane and finally lysis. Biological Effects of Complement • Chemotaxis
• Opsonization
• Hypersensitivity reaction
• Cytolysis
• Enhancement of Antibody Production
Chemotaxis • C5a is a chemotactic molecule specifically recognized by polymorphonuclear leukocytes or phagocytic cells.
• This substance causes leukocytes to migrate to a
tissue in which an antigen-antibody reaction is taking place. At that site, a phagocytic cell recognizes opsonized particles and ingests them Cont. • C5a not only has a chemotactic effect on neutrophils, but also activates these cells causing their reversible aggregation and release of stored enzymes, including proteases. • • C5a also enhances the adhesiveness of neutrophils to the endothelium Opsonizaton • Complement plays an important role in opsonization of pathogenic bacteria and viruses. these pathogrns are easily phagocytosed in the presence of complement component C3b.
• This is because the receptors for the C3b
component are present on the surface of many phagocytes. Hypersensitivity Reaction • Complement participates in type II (cytotoxic) and type III (immune-complex) hypersensitivity reactions. • The C3a, C4a, and C5a components stimulate degranulation of mast cells with release of mediators, such as histamine. • The C3a fragments bind to receptors on basophils and mast cells and induce the release of stored vasoactive amines (e.g., histamine) and heparin. Cytolysis • Complement mediates cytolysis. Insertion of C5b–9 complex (MAC) into the cell membrane leads to killing or lysis of erythrocytes, bacteria, and tumor cells. • The insertion of the MAC complex results in disruption of the membrane, there by leading to entry of water and electrolytes into the cell. Enhancement of antibody production • The binding of C3b to the surface receptors on the activated B cells markedly enhances the production of antibodies in comparison to that of B cells activated by antigen alone. • Hence, deficiency of C3b leads to reduced production of antibodies. Therefore, low concentration of both C3b and antibodies affects host defense, resulting in severe pyogenic infections. Deficiency of complement Deficiency of various components may result in many diseases as follows: • Inherited deficiency of C1 esterase inhibitors causes angioedema. The low level of C1 esterase inhibitors leads to overproduction of esterase. This leads to an increase in release of anaphylatoxins, which cause capillary permeability and edema. Cont. • Acquired deficiency of DAF results in an increase in complement- mediated hemolysis. The condition manifests clinically as paroxysmal nocturnal hemoglobinuria. • Inherited or acquired deficiency of C5–8 components greatly enhances susceptibility to Neisseria bacteremia and other infections. Deficiency of C3 leads to severe recurrent pyogenic sinusitis and respiratory infections Cont. • The synthesis of sufficient quantities of complement is reduced in the patients with severe liver disease, such as chronic hepatitis or alcoholic cirrhosis.